Literature DB >> 1214015

Platelet aggregability in relation to impaired consciousness after head injury.

C J Vecht, J M Minderhoud, C T Sibinga.   

Abstract

ADP-induced platelet aggregation was studied for up to six weeks in 34 patients with head injuries. The patients were divided into three groups according to the degree of impaired consciousness assessed by a clinical coma scale, and change in platelet aggregation was related to the coma score. Platelet aggregation was markedly reduced in all eight patients dying within 24 hours of injury. All 17 patients who remained unconscious for four days or more showed decreased platelet aggregation up to nine days after admission, the most marked effect being on the second day. Platelet function in this group returned to normal within 16 days. Nine patients with only slightly impaired consciousness also showed subnormal platelet aggregation during the first few days with a return to normal by the fourth day. Platelet counts remained within normal limits in all groups. We suggest that during coma following head injury brainstem dysfunction induces neurohumoral changes in the blood which are responsible for a decrease in platelet function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1214015      PMCID: PMC475867          DOI: 10.1136/jcp.28.10.814

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Pharmacological studies with the serotonin precursor, 5-hydroxytryptophan.

Authors:  D F BOGDANSKI; H WEISSBACH
Journal:  J Pharmacol Exp Ther       Date:  1958-02       Impact factor: 4.030

3.  Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation.

Authors:  E W Salzman; E B Rubino; R V Sims
Journal:  Ser Haematol       Date:  1970

4.  Impairment of phagocytosis by granulocytes in brain-damaged patients.

Authors:  T van Woerkom; A W Teelken; J M Minderhoud
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

5.  Persistent vegetative state after brain damage. A syndrome in search of a name.

Authors:  B Jennett; F Plum
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

6.  A comparison of the serotonin and ATP content in platelets from subjects with Down's syndrome.

Authors:  S M Bayer; E E McCoy
Journal:  Biochem Med       Date:  1974-03

7.  Platelet aggregation in patients with cerebral vascular disease and in control subjects.

Authors:  G Danta
Journal:  Thromb Diath Haemorrh       Date:  1973-06-28

8.  Brain serotonin and pituitary-adrenal function.

Authors:  J Vernikos-Danellis; P Berger; J D Barchas
Journal:  Prog Brain Res       Date:  1973       Impact factor: 2.453

9.  The platelet release reaction. Its general aspects and relation to phagocytosis-pinocytosis.

Authors:  H Stormorken
Journal:  Scand J Clin Lab Invest Suppl       Date:  1969

10.  Granulocyte function in patients with brain damage and anoxia.

Authors:  H Dodsworth; R Harris
Journal:  Acta Haematol       Date:  1971       Impact factor: 2.195

View more
  3 in total

1.  Evaluation of platelet aggregability during left ventricular bypass using a MedTech MagLev VAD in a series of chronic calf experiments.

Authors:  Taro Kimura; Yoshimasa Yokoyama; Daisuke Sakota; Eiki Nagaoka; Takashi Kitao; Kazuo Takakuda; Setsuo Takatani
Journal:  J Artif Organs       Date:  2012-10-03       Impact factor: 1.731

Review 2.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 3.  Time Course of Hemostatic Disruptions After Traumatic Brain Injury: A Systematic Review of the Literature.

Authors:  Alexander Fletcher-Sandersjöö; Eric Peter Thelin; Marc Maegele; Mikael Svensson; Bo-Michael Bellander
Journal:  Neurocrit Care       Date:  2021-04       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.